BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 26830063)

  • 1. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S; Grossman B; Kopko P
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
    Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
    Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
    Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
    Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
    Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
    Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HLA sensitization in female apheresis donors.
    Densmore TL; Goodnough LT; Ali S; Dynis M; Chaplin H
    Transfusion; 1999 Jan; 39(1):103-6. PubMed ID: 9920173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
    Williams D; Rao M; Carey P
    J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.
    Triulzi DJ; Kleinman S; Kakaiya RM; Busch MP; Norris PJ; Steele WR; Glynn SA; Hillyer CD; Carey P; Gottschall JL; Murphy EL; Rios JA; Ness PM; Wright DJ; Carrick D; Schreiber GB
    Transfusion; 2009 Sep; 49(9):1825-35. PubMed ID: 19453983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
    van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
    Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
    Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
    Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of leucocyte antibodies in non-transfused male and female platelet apheresis donors.
    Simtong P; Sudwilai Y; Cheunta S; Leelayuwat C; Romphruk AV
    Transfus Med; 2021 Jun; 31(3):186-192. PubMed ID: 33949000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
    Keller-Stanislawski B; Reil A; Günay S; Funk MB
    Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.
    Kleinman SH; Triulzi DJ; Murphy EL; Carey PM; Gottschall JL; Roback JD; Carrick D; Mathew S; Wright DJ; Cable R; Ness P; Gajic O; Hubmayr RD; Looney MR; Kakaiya RM;
    Transfusion; 2011 Oct; 51(10):2078-91. PubMed ID: 21446938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
    Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
    Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.